Use of tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report J Radbel, N Narayanan, PJ Bhatt Chest 158 (1), e15-e19, 2020 | 207 | 2020 |
Risk factors and outcomes of hospitalized patients with severe coronavirus disease 2019 (COVID-19) and secondary bloodstream infections: a multicenter case-control study PJ Bhatt, S Shiau, L Brunetti, Y Xie, K Solanki, S Khalid, S Mohayya, ... Clinical Infectious Diseases 72 (12), e995-e1003, 2021 | 86 | 2021 |
Montelukast in hospitalized patients diagnosed with COVID-19 AR Khan, C Misdary, N Yegya-Raman, S Kim, N Narayanan, S Siddiqui, ... Journal of Asthma 59 (4), 780-786, 2022 | 83 | 2022 |
Effect of an electronic medical record alert for severe sepsis among ED patients N Narayanan, AK Gross, M Pintens, C Fee, C MacDougall The American Journal of Emergency Medicine 34 (2), 185-188, 2016 | 66 | 2016 |
Disaster preparedness: biological threats and treatment options N Narayanan, CR Lacy, JE Cruz, M Nahass, J Karp, JA Barone, ... Pharmacotherapy: The journal of human pharmacology and drug therapy 38 (2 …, 2018 | 53 | 2018 |
Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients D Dixit, MB Bridgeman, LB Andrews, N Narayanan, J Radbel, A Parikh, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (6 …, 2015 | 45 | 2015 |
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia N Narayanan, R Rai, P Vaidya, A Desai, T Bhowmick, MP Weinstein Therapeutic advances in infectious disease 6, 2049936119828964, 2019 | 28 | 2019 |
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia MR Hovan, N Narayanan, V Cedarbaum, T Bhowmick, TJ Kirn Diagnostic Microbiology and Infectious Disease 101 (4), 115505, 2021 | 27 | 2021 |
Results of a hepatitis C virus screening program of the 1945–1965 birth cohort in a large emergency department in New Jersey JK Cornett, V Bodiwala, V Razuk, D Shukla, N Narayanan Open forum infectious diseases 5 (4), ofy065, 2018 | 23 | 2018 |
Impact of vancomycin MIC on clinical outcomes of patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin at an institution with suppressed … S Adani, T Bhowmick, MP Weinstein, N Narayanan Antimicrobial agents and chemotherapy 62 (4), 10.1128/aac. 02512-17, 2018 | 19 | 2018 |
Economic and health care burdens of hepatitis delta: a study of commercially insured adults in the United States MI Elsaid, Y Li, T John, N Narayanan, C Catalano, VK Rustgi Hepatology 72 (2), 399-411, 2020 | 17 | 2020 |
The present and future state of antimicrobial stewardship and rapid diagnostic testing: can one ideally succeed without the other? K Zeitler, N Narayanan Current Treatment Options in Infectious Diseases 11, 177-187, 2019 | 14 | 2019 |
Pharmacists’ perceptions and drivers of immunization practices for COVID-19 vaccines: results of a nationwide survey prior to COVID-19 vaccine emergency use authorization SS Jacob, MB Bridgeman, H Kim, M Toscani, R Kohler, S Shiau, ... Pharmacy 9 (3), 131, 2021 | 12 | 2021 |
A comprehensive survey of infectious diseases curriculum among US pharmacy schools MN Jeffres, WD Kufel, LR Biehle, JC Cho, N Narayanan, K Gruenberg, ... American Journal of Pharmaceutical Education 83 (9), 2019 | 12 | 2019 |
Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient N Narayanan, CD Adams, DW Kubiak, S Cheng, R Stoianovici, L Kagan, ... Infection and drug resistance, 877-891, 2019 | 11 | 2019 |
Collaboration between an antimicrobial stewardship team and the microbiology laboratory can shorten time to directed antibiotic therapy for methicillin-susceptible … T Bhowmick, TJ Kirn, F Hetherington, S Takavarasha, SS Sandhu, ... Diagnostic microbiology and infectious disease 92 (3), 214-219, 2018 | 11 | 2018 |
The role of an antimicrobial stewardship team in the use of rapid diagnostic testing in acute care: an official position statement of the Society of Infectious Diseases Pharmacists B Hill, N Narayanan, E Palavecino, KK Perez, S Premraj, A Streifel, ... infection control & hospital epidemiology 39 (4), 473-475, 2018 | 11 | 2018 |
Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections M Hogan, MB Bridgeman, GH Min, D Dixit, PJ Bridgeman, N Narayanan Infection and drug resistance, 1975-1981, 2018 | 10 | 2018 |
Health care utilization and economic burdens of hemochromatosis in the United States: a population-based claims study MI Elsaid, T John, Y Li, S Koduru, SZ Ali, C Catalano, N Narayanan, ... Journal of managed care & specialty pharmacy 25 (12), 1377-1386, 2019 | 8 | 2019 |
Beyond susceptible and resistant, part III: treatment of infections due to Gram-negative organisms producing carbapenemases N Narayanan, L Johnson, C MacDougall The Journal of Pediatric Pharmacology and Therapeutics 21 (2), 110-119, 2016 | 7 | 2016 |